LGVN - Is It Too Late to Buy Longeveron Stock?
Up nearly 400% in the last month alone, Longeveron (NASDAQ: LGVN) is doubtlessly one of the more volatile biotechs in the longevity space. Between its brief dalliance with meme stock traders in November and recent progress with regulatory authorities, plenty of people have made a lot of money on the stock.
However, when it comes to the prospect of newcomers making money, the prospects are less certain. With positive catalysts in the rearview mirror, there isn't much on the radar that could send its shares toward the moon. Is it still worth investing in this stock, or is it all downhill from here?
Image source: Getty Images.
For further details see:
Is It Too Late to Buy Longeveron Stock?